Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · IEX Real-Time Price · USD
5.21
+0.05 (0.97%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Alignment Healthcare Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for ALHC stock have an average target of 8.86, with a low estimate of 4.50 and a high estimate of 12. The average target predicts an increase of 70.06% from the current stock price of 5.21.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ALHC stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 2 |
| Buy | 3 | 3 | 3 | 3 | 1 | 1 |
| Hold | 4 | 4 | 4 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +72.74% | Apr 23, 2024 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $12 → $6 | Buy → Hold | Downgrades | $12 → $6 | +15.16% | Mar 6, 2024 |
| Barclays | Barclays | Sell Initiates $4.5 | Sell | Initiates | $4.5 | -13.63% | Mar 6, 2024 |
| UBS | UBS | Hold Maintains $9 → $8.5 | Hold | Maintains | $9 → $8.5 | +63.15% | Feb 28, 2024 |
| Stifel | Stifel | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +111.13% | Jan 24, 2024 |
Financial Forecast
Revenue This Year
2.11B
from 1.82B
Increased by 15.76%
Revenue Next Year
2.45B
from 2.11B
Increased by 16.06%
EPS This Year
-0.21
from -0.79
EPS Next Year
-0.59
from -0.21
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 2.5B | 3.2B | 3.3B | 4.0B |
| Avg | 2.5B | 2.9B | 3.2B | 3.8B |
| Low | 2.3B | 2.7B | 3.1B | 3.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 39.7% | 30.2% | 11.3% | 24.6% |
| Avg | 34.3% | 20.0% | 8.1% | 21.1% |
| Low | 28.8% | 9.8% | 3.8% | 16.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -0.32 | -0.22 | -0.25 | -0.05 |
| Avg | -0.59 | -0.48 | -0.24 | -0.05 |
| Low | -0.74 | -0.58 | -0.24 | -0.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.